Lockdowns Didn't Hurt Ovarian Cancer Survival
When the world shut down in 2020, hospitals faced a scary reality. Many patients waited longer for appointments, and doctors had to make hard choices about who got care first. For women with ovarian cancer, this meant fewer surgeries and delayed treatments. But a new look at data from a major Swiss hospital tells a different story. The pandemic did not make the disease worse for those who needed it most.
Ovarian cancer is often called a "silent killer" because symptoms are vague and hard to spot early. It affects women of all ages, but the risk grows as people get older. During the pandemic, many women stopped going to the doctor because they were afraid of getting sick or simply couldn't get an appointment.
This fear led to a drop in diagnoses in 2020 and 2021. Doctors saw fewer new cases simply because fewer women were being tested. This is a serious problem because early detection saves lives. However, the hospital team wanted to know if the delay actually hurt the women who were already sick. Did waiting make the cancer spread faster? Did it lower their survival rates?
The Surprising Shift in Surgery
Before the pandemic, doctors usually tried to remove all visible tumors right away. This is called primary surgery. It was the standard plan for years. But during the lockdowns, safety rules changed. Surgeons had to be extra careful to avoid spreading the virus in the hospital.
This led to a change in strategy. More doctors chose a different approach called interval debulking. They waited for the virus to calm down before operating. They gave patients a break first, then returned to remove the tumors. This might sound like a delay, but it was actually a safety measure. The question was whether waiting made the cancer harder to treat.
Think of the cancer like a garden with weeds growing everywhere. The goal of surgery is to pull out as many weeds as possible. If you leave some behind, they can grow back quickly.
The new strategy was like waiting for a storm to pass before gardening. Doctors waited for the pandemic to ease, then returned to the garden. They used the same tools and techniques as before. The only difference was the timing. They waited a few months, then went back to work. The hope was that patients would be safer during the operation, and the cancer would still be treatable.
Researchers looked at 218 women who had ovarian cancer or a related tumor at Bern University Hospital. They checked records from 2019 through 2022. They found that diagnoses dropped in 2020 and 2021, just as expected. But the stage of the cancer did not change. Women were not diagnosed with more advanced disease just because they waited.
For the 131 women with advanced cancer, the results were very encouraging. Eighty-four percent of them still had surgery to remove their tumors. This number stayed the same even during the pandemic. Doctors achieved complete removal of visible tumors in 89% of cases. This rate did not drop during the hard times.
Women also received chemotherapy, which is drug treatment to kill cancer cells. Ninety-four percent of advanced patients got this treatment. The type of drugs and how they were given did not change. Most importantly, the study found no increase in death or cancer coming back for women diagnosed during the pandemic years.
But There Is A Catch
This doesn't mean this treatment is available yet.
The study was done at one specific hospital in Switzerland. It is a top-tier center with excellent resources. Not every hospital can do what this team did. Smaller clinics might not have the same staff or equipment. Also, the study only looked at one type of cancer and one location. We need to see if other hospitals get the same good results.
What Experts Say
Doctors who reviewed the data agree with the findings. They say that safety measures did not have to come at the cost of patient care. The key was communication. Doctors kept lines open with patients who were worried. They offered telehealth visits so women could ask questions without leaving home. This helped keep trust high even when the hospital doors felt closed.
The team also notes that the drop in diagnoses was real. Many women were scared to come in. This means we still need to work on getting women to seek care. Fear of the virus should not stop someone from checking for cancer.
If you or a loved one has ovarian cancer, do not delay care because of fear. The data shows that waiting a few months for safety did not hurt survival. Talk to your doctor about your concerns. Ask if your hospital has a plan for safe surgery during tough times.
You can also advocate for yourself. If you feel you are being turned away, ask why. Sometimes a simple call to a patient advocate can help. Remember that medical teams want to help you. They are trained to handle these situations safely.
The Limitations
This study has some limits. It only looked at patients at one hospital. That hospital is very large and well-staffed. Results might be different at smaller clinics with fewer doctors. Also, the study only covered four years. We do not know what will happen five or ten years from now. Long-term data takes time to collect.
The next step is to share these results with other hospitals. Doctors need to know that safety and speed can go together. We need more studies from different parts of the world to confirm these findings. If other hospitals see the same results, guidelines might change.
Until then, the message is clear. The pandemic did not make ovarian cancer worse for those who got treatment. It changed how doctors worked, but the outcome remained strong. Patients should feel confident in their care, even during uncertain times.